{"id":"W4232907328","doi":"10.1056/nejmoa066403","title":"Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Valeant Pharmaceuticals International; Gilead Sciences; Vertex Pharmaceuticals; GlaxoSmithKline","keywords":"Medicine; Ribavirin; Regimen; Internal medicine; Gastroenterology; Peginterferon alfa-2a; Hepatitis C virus; Liter; Odds ratio; Hepatitis C; Randomized controlled trial; Confidence interval; Surgery; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003199045,0.001072856,0.001833892,0.0002680304,0.0005635823,0.000479172,0.0005959981,0.001782251,0.003441433],"category_scores_gemma":[0.002836224,0.000567107,0.001694964,0.0003598917,0.001183933,0.001075041,0.0005531373,0.002938699,0.0005175867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007007244,"about_ca_system_score_gemma":0.001536562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001234416,"about_ca_topic_score_gemma":0.002956754,"domain_scores_codex":[0.9984834,0.001055215,0.00007552769,0.0001287069,0.00006515105,0.0001920085],"domain_scores_gemma":[0.9986156,0.0003966212,0.0003385539,0.0001141069,0.00004294828,0.0004921305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9636054,0.009649709,0.001723259,0.0001944139,0.0005529671,0.00004723925,0.00005418243,0.0002933763,0.002378014,0.00005711639,0.0004595122,0.02098466],"study_design_scores_gemma":[0.8790908,0.1146994,0.004168276,0.00002985535,0.0003091999,0.00004446886,0.00001758668,0.0002183444,0.0006971384,0.0001078807,0.0006052671,0.0000118465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940892,0.002319981,0.0002933774,0.0006283055,0.0002135089,0.001271651,0.0002482128,0.00003653027,0.000899158],"genre_scores_gemma":[0.9934072,0.001052257,0.0009053631,0.0009143821,0.000244334,0.002002568,0.0003230882,0.00001168186,0.001139085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003441433,"threshold_uncertainty_score":0.01691836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07762475862658684,"score_gpt":0.3874304482813447,"score_spread":0.3098056896547579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}